We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current COV market cap is 12.97M. The company's latest EPS is AUD -0.0233 and P/E is -7.30.
Year End June 29 2023 | 2022 | 2023 |
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Revenue | 0 | 110k |
Operating Income | -43k | -1.62M |
Net Income | -44k | -1.73M |
Year End June 29 2023 | 2022 | 2023 |
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Assets | 244k | 1.08M |
Total Liabilities | 286k | 2.02M |
Total Equity | -42k | -943k |
Year End June 29 2023 | 2022 | 2023 |
---|---|---|
AUD (AUD) | AUD (AUD) | |
Operating | N/A | -684k |
Investing | -200k | -340k |
Financing | 242k | 1.22M |
Market Cap | 12.97M |
Price to Earnings Ratio | -7.30 |
Price to Sales Ratio | 113.33 |
Price to Cash Ratio | 53.13 |
Price to Book Ratio | -13.36 |
Dividend Yield | - |
Shares Outstanding | 74.1M |
Average Volume (1 week) | 62.95k |
Average Volume (1 Month) | 78.06k |
52 Week Change | -23.91% |
52 Week High | 0.23 |
52 Week Low | 0.14 |
Spread (Intraday) | 0.03 (12.82%) |
Company Name | Cleo Diagnostics Ltd |
Address |
level 2, 480 collins street, melbourne vic 3000 melbourne, victoria 3000 |
Website | https://cleodx.com |
Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions